Doximity, Inc. $DOCS Shares Sold by Swedbank AB

Key Points

• Swedbank AB decreased its stake in Doximity, Inc. by 33.8% during the first quarter, selling 47,799 shares and maintaining a total of 93,683 shares valued at $5.436 million.
• Other institutional investors like Vanguard Group Inc. and Invesco Ltd. increased their holdings in Doximity, reflecting broader interest in the company's stock.
• Analysts have mixed ratings for Doximity, with a consensus rating of "Moderate Buy" and a price target around $67.00, while earnings reports showed a year-over-year revenue increase of 15.2%.

Swedbank AB cut its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 33.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 93,683 shares of the company's stock after selling 47,799 shares during the quarter. Swedbank AB's holdings in Doximity were worth $5,436,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. VSM Wealth Advisory LLC bought a new stake in shares of Doximity in the 1st quarter worth approximately $29,000. Allworth Financial LP increased its position in Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares during the period. National Bank of Canada FI purchased a new stake in shares of Doximity in the 1st quarter worth about $33,000. Spire Wealth Management grew its position in shares of Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after buying an additional 260 shares during the period. Finally, Brooklyn Investment Group grew its position in shares of Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after buying an additional 309 shares during the period. 87.19% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Doximity news, Director Regina M. Benjamin sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the transaction, the director directly owned 16,618 shares in the company, valued at approximately $997,080. The trade was a 37.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares of the company's stock, valued at $948,721.62. This represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 37,000 shares of company stock worth $2,281,880. 31.30% of the stock is owned by corporate insiders.

Doximity Trading Down 1.0%

Shares of DOCS traded down $0.71 during trading hours on Friday, reaching $72.89. 2,853,244 shares of the company traded hands, compared to its average volume of 2,206,223. Doximity, Inc. has a 12-month low of $40.15 and a 12-month high of $85.21. The stock's fifty day moving average price is $64.76 and its 200 day moving average price is $60.03. The firm has a market cap of $13.65 billion, a price-to-earnings ratio of 72.89, a PEG ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The company's revenue was up 15.2% compared to the same quarter last year. During the same period last year, the firm earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have issued reports on DOCS. Raymond James Financial set a $75.00 target price on shares of Doximity in a research note on Wednesday, September 10th. Wells Fargo & Company upped their target price on shares of Doximity from $55.00 to $62.00 and gave the company an "equal weight" rating in a research note on Monday, August 4th. Truist Financial upped their target price on shares of Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a research note on Thursday, July 17th. BTIG Research upgraded shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price objective on the stock in a research note on Monday, June 2nd. Finally, Needham & Company LLC increased their price objective on shares of Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $67.42.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.